Radioimmunoassay (RIA) Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
Radioimmunoassay (RIA) Trends and Forecast
The future of the global radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets. The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Radioimmunoassay (RIA) by Segment
The study includes a forecast for the global radioimmunoassay (RIA) by type, application, end use, and region.
Radioimmunoassay (RIA) Market by Type [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radioimmunoassay (RIA) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radioimmunoassay (RIA) companies profiled in this report include-
Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.
Within this market, clinical diagnostic laboratory is expected to witness the highest growth due to substantial usage of radioimmunoassay in this facility given to their ability to analyze a broad variety of analytes in biological samples with high throughput, high sensitivity, and specificity.
North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.
Features of the Global Radioimmunoassay (RIA) Market
Market Size Estimates: Radioimmunoassay (RIA) market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Radioimmunoassay (RIA) market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: Radioimmunoassay (RIA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the radioimmunoassay (RIA) market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radioimmunoassay (RIA) market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for radioimmunoassay (RIA) market?
Answer: The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the radioimmunoassay (RIA) market?
Answer: The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.
Q3. What are the major segments for radioimmunoassay (RIA) market?
Answer: The future of the radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets.
Q4. Who are the key radioimmunoassay (RIA) market companies?
Answer: Some of the key radioimmunoassay (RIA) companies are as follows:
Answer: Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.
Q6. In radioimmunoassay (RIA) market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the radioimmunoassay (RIA) market by type (reagents & kits and analyzers), application (clinical diagnostics and research), end use (hospitals, pharmaceuticals, academics, clinical diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Radioimmunoassay (RIA) Market, Radioimmunoassay (RIA) Market Size, Radioimmunoassay (RIA) Market Growth, Radioimmunoassay (RIA) Market Analysis, Radioimmunoassay (RIA) Market Report, Radioimmunoassay (RIA) Market Share, Radioimmunoassay (RIA) Market Trends, Radioimmunoassay (RIA) Market Forecast, Radioimmunoassay (RIA) Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Radioimmunoassay (RIA) Trends and Forecast
The future of the global radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets. The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030. The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Radioimmunoassay (RIA) by Segment
The study includes a forecast for the global radioimmunoassay (RIA) by type, application, end use, and region.
Radioimmunoassay (RIA) Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Reagents & Kits
- Analyzers
- Clinical Diagnostics
- Research
- Hospitals
- Pharmaceuticals
- Academics
- Clinical Diagnostic Laboratories
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radioimmunoassay (RIA) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radioimmunoassay (RIA) companies profiled in this report include-
- DiaSource ImmunoAssays
- Beckman Coulter
- IBL International
- PerkinElmer
- DRG International
- MP Biomedicals
- Cisbio
- Euro Diagnostica
- DiaSorin
- EMD Millipore
Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.
Within this market, clinical diagnostic laboratory is expected to witness the highest growth due to substantial usage of radioimmunoassay in this facility given to their ability to analyze a broad variety of analytes in biological samples with high throughput, high sensitivity, and specificity.
North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.
Features of the Global Radioimmunoassay (RIA) Market
Market Size Estimates: Radioimmunoassay (RIA) market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Radioimmunoassay (RIA) market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: Radioimmunoassay (RIA) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the radioimmunoassay (RIA) market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radioimmunoassay (RIA) market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for radioimmunoassay (RIA) market?
Answer: The global radioimmunoassay (RIA) market is expected to grow with a CAGR of 3.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the radioimmunoassay (RIA) market?
Answer: The major drivers for this market are increasing rates of cancer incidence, growing need for automation in healthcare, and rising advancement in medical research.
Q3. What are the major segments for radioimmunoassay (RIA) market?
Answer: The future of the radioimmunoassay (RIA) market looks promising with opportunities in the hospital, pharmaceutical, academic, and clinical diagnostic laboratory markets.
Q4. Who are the key radioimmunoassay (RIA) market companies?
Answer: Some of the key radioimmunoassay (RIA) companies are as follows:
- DiaSource ImmunoAssays
- Beckman Coulter
- IBL International
- PerkinElmer
- DRG International
- MP Biomedicals
- Cisbio
- Euro Diagnostica
- DiaSorin
- EMD Millipore
Answer: Lucintel forecasts that reagent & kit is expected to witness higher growth over the forecast period.
Q6. In radioimmunoassay (RIA) market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to availability of favorable reimbursement policy and existence of robust healthcare system in the region.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the radioimmunoassay (RIA) market by type (reagents & kits and analyzers), application (clinical diagnostics and research), end use (hospitals, pharmaceuticals, academics, clinical diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Radioimmunoassay (RIA) Market, Radioimmunoassay (RIA) Market Size, Radioimmunoassay (RIA) Market Growth, Radioimmunoassay (RIA) Market Analysis, Radioimmunoassay (RIA) Market Report, Radioimmunoassay (RIA) Market Share, Radioimmunoassay (RIA) Market Trends, Radioimmunoassay (RIA) Market Forecast, Radioimmunoassay (RIA) Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL RADIOIMMUNOASSAY (RIA) MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Radioimmunoassay (RIA) Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Radioimmunoassay (RIA) Market by Type
3.3.1: Reagents & Kits
3.3.2: Analyzers
3.4: Global Radioimmunoassay (RIA) Market by Application
3.4.1: Clinical Diagnostics
3.4.2: Research
3.5: Global Radioimmunoassay (RIA) Market by End Use
3.5.1: Hospitals
3.5.2: Pharmaceuticals
3.5.3: Academics
3.5.4: Clinical Diagnostic Laboratories
3.5.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Radioimmunoassay (RIA) Market by Region
4.2: North American Radioimmunoassay (RIA) Market
4.2.1: North American Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.2.2: North American Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
4.3: European Radioimmunoassay (RIA) Market
4.3.1: European Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.3.2: European Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
4.4: APAC Radioimmunoassay (RIA) Market
4.4.1: APAC Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.4.2: APAC Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
4.5: ROW Radioimmunoassay (RIA) Market
4.5.1: ROW Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.5.2: ROW Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Type
6.1.2: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Application
6.1.3: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by End Use
6.1.4: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Region
6.2: Emerging Trends in the Global Radioimmunoassay (RIA) Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Radioimmunoassay (RIA) Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radioimmunoassay (RIA) Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: DiaSource ImmunoAssays
7.2: Beckman Coulter
7.3: IBL International
7.4: PerkinElmer
7.5: DRG International
7.6: MP Biomedicals
7.7: Cisbio
7.8: Euro Diagnostica
7.9: DiaSorin
7.10: EMD Millipore
2. GLOBAL RADIOIMMUNOASSAY (RIA) MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Radioimmunoassay (RIA) Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Radioimmunoassay (RIA) Market by Type
3.3.1: Reagents & Kits
3.3.2: Analyzers
3.4: Global Radioimmunoassay (RIA) Market by Application
3.4.1: Clinical Diagnostics
3.4.2: Research
3.5: Global Radioimmunoassay (RIA) Market by End Use
3.5.1: Hospitals
3.5.2: Pharmaceuticals
3.5.3: Academics
3.5.4: Clinical Diagnostic Laboratories
3.5.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Radioimmunoassay (RIA) Market by Region
4.2: North American Radioimmunoassay (RIA) Market
4.2.1: North American Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.2.2: North American Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
4.3: European Radioimmunoassay (RIA) Market
4.3.1: European Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.3.2: European Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
4.4: APAC Radioimmunoassay (RIA) Market
4.4.1: APAC Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.4.2: APAC Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
4.5: ROW Radioimmunoassay (RIA) Market
4.5.1: ROW Radioimmunoassay (RIA) Market by Type: Reagents & Kits and Analyzers
4.5.2: ROW Radioimmunoassay (RIA) Market by End Use: Hospitals, Pharmaceuticals, Academics, Clinical Diagnostic Laboratories, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Type
6.1.2: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Application
6.1.3: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by End Use
6.1.4: Growth Opportunities for the Global Radioimmunoassay (RIA) Market by Region
6.2: Emerging Trends in the Global Radioimmunoassay (RIA) Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Radioimmunoassay (RIA) Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radioimmunoassay (RIA) Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: DiaSource ImmunoAssays
7.2: Beckman Coulter
7.3: IBL International
7.4: PerkinElmer
7.5: DRG International
7.6: MP Biomedicals
7.7: Cisbio
7.8: Euro Diagnostica
7.9: DiaSorin
7.10: EMD Millipore
